QS Investors, LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 149 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$1,062,000
+61.9%
44,400
-1.1%
0.01%
+50.0%
Q4 2020$656,000
+2.8%
44,9000.0%0.01%
-11.1%
Q3 2020$638,000
-81.5%
44,900
-80.9%
0.01%
-81.2%
Q2 2020$3,456,000
+207.5%
234,900
-13.8%
0.05%
+166.7%
Q1 2020$1,124,000
-12.8%
272,6000.0%0.02%
+38.5%
Q4 2019$1,289,000
-22.0%
272,6000.0%0.01%
-27.8%
Q3 2019$1,652,000272,6000.02%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders